We are live on ! Find out more
CCXI

ChemoCentryx, Inc.
CCXI

Delisted

CCXI was delisted on the 19th of October, 2022.

Back to rankings

87 hedge funds and large institutions have $141M invested in ChemoCentryx, Inc. in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $165K | Put options by funds: $78K

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

1% more funds holding

Funds holding: 86 → 87 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less capital invested

Capital invested by funds: $177M → $141M (-$36.1M)

Holders
87
Holders Change
+1
Holders Change %
+1.16%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
31
Reduced
25
Closed
6
Calls
$165K
Puts
$78K
Net Calls
+$87K
Net Calls Change
-$114K

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
+$1.83M
2
UC
Unterberg Capital
New York
+$686K
3
Morgan Stanley
Morgan Stanley
New York
+$400K
4
SCM
Sio Capital Management
New York
+$400K
5
Goldman Sachs
Goldman Sachs
New York
+$320K

Top Sellers

1
IHM
Iguana Healthcare Management
New York
-$1.2M
2
Deutsche Bank
Deutsche Bank
Germany
-$880K
3
ZIM
Zacks Investment Management
Illinois
-$589K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$583K
5
ADEF
Adams Diversified Equity Fund
Maryland
-$533K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$45.1M – – –
BlackRock
2
BlackRock
New York
$16.3M -$217K -31,586 -1%
WA
3
Wasatch Advisors
Utah
$13M -$253K -36,877 -2%
Franklin Resources
4
Franklin Resources
California
$11.9M -$436K -63,500 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.36M +$32.8K +4,782 +0.4%
NCM
6
Nantahala Capital Management
Connecticut
$5.62M +$1.83M +267,295 +39%
Renaissance Technologies
7
Renaissance Technologies
New York
$5.14M -$434K -63,300 -7%
AG
8
Artal Group
Luxembourg
$2.98M – – –
State Street
9
State Street
Massachusetts
$2.64M +$105K +15,296 +4%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$2.61M -$400K -58,357 -12%
PAM
11
Panagora Asset Management
Massachusetts
$1.68M +$111K +16,120 +6%
Northern Trust
12
Northern Trust
Illinois
$1.64M +$2.93K +427 +0.2%
Goldman Sachs
13
Goldman Sachs
New York
$1.59M +$320K +46,626 +21%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$1.53M +$84.7K +12,343 +5%
Millennium Management
15
Millennium Management
New York
$1.52M +$254K +37,069 +17%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.42M -$27.1K -3,955 -2%
OAM
17
Oxford Asset Management
United Kingdom
$1.31M -$169K -24,577 -10%
Deutsche Bank
18
Deutsche Bank
Germany
$1.11M -$880K -128,344 -41%
PAWC
19
P.A.W. Capital
Connecticut
$952K – – –
Morgan Stanley
20
Morgan Stanley
New York
$894K +$400K +58,323 +64%
SIM
21
Spark Investment Management
New York
$863K -$147K -21,400 -13%
TCIM
22
TIAA CREF Investment Management
New York
$721K +$76.3K +11,124 +10%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$660K +$2.22K +324 +0.3%
IHM
24
Iguana Healthcare Management
New York
$595K -$1.2M -175,000 -64%
UC
25
Unterberg Capital
New York
$595K +$686K +100,000 New
1
2 3 4

CCXI Hedge Fund Activity: Q4 2017 in Review

87 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2017, worth a combined $141M — down 20% from $177M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CCXI positions and 6 closed out — a net gain of 1 holder — while 31 added to existing stakes and 25 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $1.83M. The largest seller was Iguana Healthcare Management, cutting an estimated $1.2M.

  • 87 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2017, up from 86 in Q3 2017.
  • Funds reported $141M of ChemoCentryx, Inc. stock for Q4 2017, down 20% quarter-over-quarter.
  • 7 funds opened new ChemoCentryx, Inc. positions in Q4 2017 and 6 closed out, a net change of +1 holder.
  • The largest ChemoCentryx, Inc. buyer in Q4 2017 was Nantahala Capital Management, an estimated $1.83M added.
  • The largest ChemoCentryx, Inc. seller in Q4 2017 was Iguana Healthcare Management, an estimated $1.2M sold.

Based on aggregated 13F filings for Q4 2017.